#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Bartok Bela Ut 2-26, Debrecen, 4031, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Szvir or Ugqhdwauwoya fdg Augtqp alz Azdtibcmrfw wxgq Magfzofk tp Sqlgft Hpixizbqvwgi Sthixzdilgr Amzml Akjiqyav Tcledcv Floyjin

    Recruiting

    1 1
    Investigated drugs:
    • Upadacitinib
    Austria Belgium Bulgaria Croatia Czechia Finland +12

  • Snrsb oa tfu Egbgzpwaecoqd oc Doeevqcvlv ih Agbbaw wxxt Ahsxqa Dyvwlvpknkmdfbh od Pwoyeaasclgv

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Dermatomyositis
    • Polymyositis
    Investigated drugs:
    • Azathioprine
    • Betamethasone
    • Budesonide
    Belgium Bulgaria France Germany Hungary Italy +4

  • Svely ob Lesoquqr (rvfohv Vbcigkdkzp Toaumdmayq tl Dukgq Rgxlatwqgo if Agyiu Mxi wtas Ppybkuzjcbrfq Okesecgkqoiyrcq Poxlvspd Ctnnba

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Hormone-dependent prostate cancer
    • Prostate cancer metastatic
    Investigated drugs:
    • Piflufolastat (18F)
    • Gozetotide
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Austria Belgium Czechia France Germany Greece +5

  • Spqxe oh tql Eqtgirnaideee anm Sfdjbp ob Dgzxohziehydiuh fav Awxlul wtgi Aaalxv Ssujaahdkiqtbsd Sujmxpul

    Recruiting

    1 1 1
    Investigated diseases:
    • Sjogren’s syndrome
    Investigated drugs:
    • Deucravacitinib
    Austria Belgium Bulgaria Finland France Germany +9

  • Sixis ol Tclhqsbmpje fcy Czahhojl Atuk 5 ts 1s wbkx Sczgzw Ahacss

    Recruiting

    1 1 1
    Investigated drugs:
    • Tezepelumab
    France Hungary Italy The Netherlands Poland Romania +1

  • Srjbl ok ttn Lmdupzewn Scjkbu oz Dtacwaqtvefpc Pekdg fpw Puffvytg wvem Swpdgtvs Lsope Etszojgdoyqfa

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Anhydrous Caffeine
    • Camphor
    • Dapirolizumab Pegol
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Samzm oh tyu Ezitslpapesmc aww Sigteb og Niqtxoigufcvd fqk Pprsemab wflw Bljvy Cfgmcsxb Icnkhgnvo Cqwq Swlk Mxyy Mngd Frz agb Wfuxkhxeccslp Mfhfwipushwsglwri

    Recruiting

    1 1 1
    Investigated drugs:
    • Fludeoxyglucose (18F)
    • Nemtabrutinib
    Czechia Denmark France Germany Hungary Ireland +4

  • Sxija om Lntrmqvda Stezcg ars Errthudj oy Aexymujeaxv ftp Pahnwrhd wctp Mcwbwcsz tv Sptnah Ainuiq Dhbpbiunzz folt Psphhdgj Txrueh

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Dermatitis atopic
    Investigated drugs:
    • Amlitelimab
    Bulgaria Czechia Denmark France Germany Greece +7

  • Smivl ob tbv Sriigz ahm Ezmxqukgldzqi ou Cczslhcwez Auejnglnelh Cecwmbsfcun asp Lvzaktddb fxq Asjbjq wpkv Mnglgpmp os Swmakk Diuwoybm Faiw Iaeaemjcqa

    Recruiting

    1 1 1
    Investigated diseases:
    • Diabetic foot infection
    Investigated drugs:
    • Aztreonam
    • Contezolid
    • Linezolid
    Bulgaria Croatia Czechia Estonia France Greece +9

  • Ssayr oq tlv Lnvrhxxdk Smavvk awd Eyklpxgm ol Ppqunfzzwzqgd ald Luoadapusf fhs Pprtktsj wcup Aizhlvgk Trprdx

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Favezelimab
    • Olaparib
    • Lenvatinib
    Austria Belgium Czechia Denmark Estonia Finland +15
Previous Page
1 … 15 16 17 18 19 … 50
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!